Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Réseau Comète INSERM.

Adrenocortical carcinoma (ACC) is a rare tumour with a poor prognosis. Cisplatin is the most widely tested cytotoxic agent in this disease. A total of 18 patients with advanced ACC were enrolled. Cytotoxic therapy consisted of etoposide (VP16) (100 mg m(-2) day(-1) on days 1-3) and cisplatin (100 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonacci, R., Gigliotti, A., Baudin, E., Wion-Barbot, N., Emy, P., Bonnay, M., Cailleux, A. F., Nakib, I., Schlumberger, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063075/
https://www.ncbi.nlm.nih.gov/pubmed/9716042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063075/
https://www.ncbi.nlm.nih.gov/pubmed/9716042

Ejemplares similares